PATH
Menu

PATH will join an international gathering of tuberculosis (TB) researchers, health policymakers, health providers, and civil society leaders at the 44th Union World Conference on Lung Health in Paris, France, from October 30 through November 3.

TB is a curable respiratory disease that infects one-third of the world’s population and kills nearly 1.4 million people each year. It remains the leading cause of death for people with HIV and takes the lives of more women per year than all causes of maternal mortality combined.

The conference theme “Shared Air, Safe Air?” provides leaders from 125 countries an opportunity to develop strategies to preserve air quality and reduce the preventable spread of airborne infections. Participants will present breakthrough research and discuss program developments in TB and related health areas, including HIV and TB coinfection, other lung diseases, relevant noncommunicable diseases, and tobacco control.

Our featured work

PATH staff and partners from nine countries will participate in more than 60 high-level meetings and events, including:

  • A symposium on “Measuring the Contribution of Advocacy, Communication and Social Mobilization (ACSM) to Increased TB Case Detection and Improved Treatment Outcomes.” Join PATH, United States Agency for International Development (USAID), and the Africa Coalition on TB to explore effective models for coordinating and improving results and communicating success. Speakers from India, Mexico, Nigeria, Tanzania, and the United States will present approaches, insights, and lessons learned. November 2, 8:00–10:00 am.
  • An abstract session on “Identifying Barriers to the Treatment and Prevention of Tuberculosis in Children, Tanzania.” November 3, 12:45–1:45 pm.
  • An abstract session on “Assessing Knowledge, Attitudes, and Practice in the Treatment of Tuberculosis, Ethiopia.” November 1, 12:45–2:45 pm.
  • A poster presentation on “Patients’ Perceived Barriers to Access and Use of Public TB Diagnostic Services in Vietnam.” November 1, 10:15–11:15 am.
  • A poster discussion on “Increasing the Number of Sputum Specimens Tested for MDR-TB, and Cases Detected by Using Expedited Mail Service Sputum Transportation in Resource-Limited Settings: A Case Study of Tanzania.” November 1, 10:15–11:15 am.

The majority of this work is funded by the USAID and is conducted with the support of our partners.

More information

Posted October 24, 2013.